Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 6Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 2234Neoplasms 2039Lung Neoplasms 1097Colorectal Neoplasms 1036Prostatic Neoplasms 894Carcinoma, Non-Small-Cell Lung 752Carcinoma, Hepatocellular 674Stomach Neoplasms 607Pancreatic Neoplasms 602Head and Neck Neoplasms 434Ovarian Neoplasms 430Colonic Neoplasms 423Rectal Neoplasms 406Uterine Cervical Neoplasms 403Esophageal Neoplasms 347Brain Neoplasms 329Neoplasm Metastasis 324Melanoma 306Multiple Myeloma 304Precursor Cell Lymphoblastic Leukemia-Lymphoma 293Urinary Bladder Neoplasms 290Leukemia, Myeloid, Acute 278Lymphoma 268Liver Neoplasms 253Endometrial Neoplasms 253Hematologic Neoplasms 252Disease 244Recurrence 225Glioma 218Carcinoma, Renal Cell 207

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Observational × Pancreatic Ductal Adenocarcinoma (PDAC) × Clear all
NCT07036978 2026-04-15

Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer

Chang Gung Memorial Hospital

Not yet recruiting
140 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

NCT06147154 2023-11-30

Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients

Qilu Hospital of Shandong University

Completed
23 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡